Chi‐Wei Yeh
Impact in
- Toxicology top 2%
- Bioactive Compounds and Antitumor Agents
-
- Ubiquitin and proteasome pathways
- Protein Degradation and Inhibitors
- Cancer therapeutics and mechanisms
Papers in
-
- Ubiquitin and proteasome pathways 4
- Protein Degradation and Inhibitors 3
- Epigenetics and DNA Methylation 2
-
- Microtubule and mitosis dynamics 2
- Co-authors
- Li‐Sung Hsu (8 shared papers)I‐Chang Chang (1 shared paper)Hsueh-Chi S. Yen (4 shared papers)You‐Cheng Hseu (3 shared papers)Hsiu‐Chuan Lin (2 shared papers)Shao‐Hsuan Kao (2 shared papers)Ning Zheng (1 shared paper)Stephen J. Elledge (1 shared paper)
- Journals
- Molecular Cell (1 paper)The EMBO Journal (1 paper)Molecular Neurobiology (1 paper)Environmental Toxicology (1 paper)Chemico-Biological Interactions (1 paper)
- Partner nations
- TaiwanUnited StatesUnited Kingdom
In The Last Decade
Chi‐Wei Yeh
14 papers receiving 437 citations
Peers
Comparison fields: 5 of 80
- Toxicology 94
- Molecular Biology 285
- Oncology 84
- Cell Biology 43
- Cancer Research 34
Countries citing papers authored by Chi‐Wei Yeh
This map shows the geographic impact of Chi‐Wei Yeh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chi‐Wei Yeh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chi‐Wei Yeh more than expected).
Fields of papers citing papers by Chi‐Wei Yeh
This network shows the impact of papers produced by Chi‐Wei Yeh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chi‐Wei Yeh. The network helps show where Chi‐Wei Yeh may publish in the future.
Co-authors
The 25 scholars most cited alongside Chi‐Wei Yeh, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 129 | |
| 2 | 2010 | 82 | |
| 3 | 2014 | 49 | |
| 4 | 2012 | 45 | |
| 5 | 2012 | 43 | |
| 6 | 2021 | 25 | |
| 7 | 2011 | 16 | |
| 8 | 2013 | 15 | |
| 9 | 2013 | 13 | |
| 10 | 2015 | 12 | |
| 11 | 1998 | 9 | |
| 12 | 2024 | 2 | |
| 13 | 2023 | 2 | |
| 14 | 2019 | 1 |
About Chi‐Wei Yeh
Chi‐Wei Yeh is a scholar working on Molecular Biology, Cell Biology, Oncology, Pharmacology and Toxicology, having authored 14 papers that have together received 443 indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (4 papers), Protein Degradation and Inhibitors (3 papers), Microtubule and mitosis dynamics (2 papers), Cancer-related Molecular Pathways (2 papers), Synthesis of Organic Compounds (2 papers), Epigenetics and DNA Methylation (2 papers), Bioactive Compounds and Antitumor Agents (2 papers) and Peptidase Inhibition and Analysis (2 papers). The work is most often cited by research in Toxicology (94 citations), Molecular Biology (285 citations), Oncology (84 citations), Cell Biology (43 citations) and Cancer Research (34 citations). Chi‐Wei Yeh has collaborated with scholars based in Taiwan, United States and United Kingdom. Frequent co-authors include Li‐Sung Hsu, I‐Chang Chang, Hsueh-Chi S. Yen, You‐Cheng Hseu, Hsiu‐Chuan Lin, Shao‐Hsuan Kao, Ning Zheng, Stephen J. Elledge, Yen‐Fu Chen and Liheng Yang. Their work appears in journals such as Molecular Cell, The EMBO Journal, Molecular Neurobiology, Environmental Toxicology and Chemico-Biological Interactions.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.